AB21(R)

AB21(R)

Products
AB21(R)
AB21(R)

Information

AB21(R) is a unique combination of 4 bacterial strains (L. plantarum KABP(TM) 033/ CECT 30292; L. plantarum KABP(TM) 022/CECT 7484; L. plantarum KABP(TM) 023/CECT 7485 and P. acidilactici KABP(TM) 021/CECT 7483) that has been shown to reduce and prevent symptoms of viral infections and to potentiate immunity after vaccination. Thanks to the detailed and meticulous investigation of AB21(R) properties, the formula is leading innovation in the probiotics and microbiome field, as the first probiotic with outstanding clinical results for the treatment of COVID-19. Condition that allowed it to win the Best Probiotic of the Year 2022, according to Nutraingredients Awards. For more info visit: www.ab21probiotic.com
Distribution Areas
Central America (e.g. Mexico)East Asia (e.g. China, Japan, Korea)Europe - EU countriesEurope - non EU (e.g. UK, Russia, ex-CIS countries)South America (e.g. Brazil, Colombia)
Supplied From
Spain
All categories
ProbioticsNatural ExtractsDietary Supplement IngredientsAPIs (Active Pharmaceutical Ingredients)Innovative APIsProducts
Main Categories
Natural ExtractsAPIs (Active Pharmaceutical Ingredients)
Ab Biotics S.A3A121AB-BIOTICS is a leading probiotics player inspired by developing probiotic solutions at the forefront of an expanding field. Whether you are interested in unique, patented strains with characterized mechanisms of action, premium probiotic solutions targeting specific therapeutic areas, or finished products with easily-communicated benefits, our agile approach allows us to adapt to your needs. With science at the heart of everything we do, our strains, blends and market-ready products are supported by robust scientific documentation.

Join the event!